Paul F. Resnick
Overview
Paul F. Resnick received $600K in total compensation, including $212K in salary, at MabVax Therapeutics Holdings in 2016.
Source: SEC filing on May 2, 2017.
Related executives
We found 11 more executives who work or worked at MabVax Therapeutics Holdings.
J Hansen
MabVax Therapeutics Holdings
Chief Executive Officer
Paul Maffuid
MabVax Therapeutics Holdings
Vice President, Pharmaceutical Development and Operations
Gregory Hanson
MabVax Therapeutics Holdings
Chief Financial Officer
Wolfgang Scholz
MabVax Therapeutics Holdings
Vice President, Antibody Discovery
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
William Kaplan
MabVax Therapeutics Holdings
General Counsel
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
Steven Schow
MabVax Therapeutics Holdings